Skip to Main content Skip to Navigation
Conference papers

A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis

Complete list of metadata

https://hal.univ-lorraine.fr/hal-01509566
Contributor : Imopa Ul Connect in order to contact the contributor
Submitted on : Tuesday, April 18, 2017 - 11:01:03 AM
Last modification on : Wednesday, June 9, 2021 - 4:02:06 PM

Links full text

Identifiers

Citation

P. Richette, E. Maheu, G. Baron, P. Ravaud, A. Rialland, et al.. A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis. Annual European Congress of Rheumatology EULAR 2013, Jun 2013, Madrid, Spain. ⟨10.1136/annrheumdis-2013-eular.223⟩. ⟨hal-01509566⟩

Share

Metrics

Record views

360